Pfizer this week unveiled its $150 million expansion project in Michigan and is ready to hire about 200 employees.

Celgene has completed the first phase of a new manufacturing facility to produce the CAR-T drug candidate it is developing with partner Bluebird Bio.

A Merck manufacturing site in Ireland that was slated to close has been saved by the drugmaker’s hot-selling cancer drug Keytruda.

ImmunoGen will turn to contractors for its manufacturing needs, a move that will mean a small facility will close and 20 workers will be let go.

The impact of an FDA warning letter issued last month for a Celltrion plant in South Korea has broadened to Teva Pharmaceuticals.

AmerisourceBergen has received a grand jury subpoena to supply info to the DOJ about its testing of a syringe made at its PharMEDium lab in Tennessee.

Partner Therapeutics, a Boston operation which had its coming-out party a week ago, today announced it bought a drug from Sanofi.

An API maker in Bizen, Japan, has joined a growing list of Japanese drugmakers to be criticized by the FDA in warning letters and bans.